LIM Kinase 1 (LIMK1) pThr508 Rabbit Polyclonal Antibody
CAT#: AP02414PU-N
LIM Kinase 1 (LIMK1) pThr508 rabbit polyclonal antibody, Aff - Purified
Size: 50 ul
Need it in bulk or conjugated?
Get a free quote
CNY 2250.00
货期*
2周
规格
Specifications
| Product Data | |
| Applications | IF, IHC, WB |
| Recommend Dilution | Western Blot: 1/500-1/1000. Immunofluorescence: 1/100-1/200. Immunohistochemistry on Paraffin Sections: 1/50-1/100. |
| Reactivity | Human, Mouse, Rat |
| Host | Rabbit |
| Clonality | Polyclonal |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human LIMK1 around the phosphorylation site of threonine 508 (R-Y-TP-V-V). |
| Specificity | This antibody detects endogenous levels of LIMK1 only when phosphorylated at Threonine 508. |
| Formulation | PBS (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02% Sodium Azide and 50% Glycerol. State: Aff - Purified State: Liquid purified Ig fraction. |
| Concentration | lot specific |
| Purification | Affinity Chromatography using epitope-specific phosphopeptide. The antibody against non-phosphopeptide was removed by chromatography using non-phosphopeptide corresponding to the phosphorylation site. |
| Conjugation | Unconjugated |
| Storage Condition | Store the antibody (in aliquots) at -20°C. Avoid repeated freezing and thawing. |
| Gene Name | LIM domain kinase 1 |
| Database Link | |
| Background | LIMK1 is a protein kinase which regulates actin filament dynamics. Phosphorylates and inactivates the actin binding/depolymerizing factor cofilin, thereby stabilizing the actin cytoskeleton. LIMK1 may be involved in brain development; it is highly expressed in both adult and fetal nervous system. Detected ubiquitously throughout the different regions of adult brain, with highest levels in the cerebral cortex. Expressed to a lesser extent in heart and skeletal muscle. |
| Synonyms | LIMK, LIM domain kinase 1, LIMK-1, EC=2.7.11.1 |
| Reference Data | |
Documents
| Product Manuals |
| FAQs |
| SDS |
Resources
| 抗体相关资料 |
Customer
Reviews
Loading...
